← Leaderboards
Nicholas Matthew McConnell
University Of Arizona
$315,494
Attributed
$315,494
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $78.4K · FY2016–20$100K$75K$50K$25K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$315,494 · 2
By mechanism
K00$226,374 · 1
F99$89,120 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Arizona
Same institution · by research overlap
- Frank Porreca$26,550,739
- Tony L Yaksh$23,138,803
- Robert J Gillies$34,169,781
- David S Alberts$22,074,619
- Gregory R J Thatcher$19,556,155
Others in their field
Top investigators on “Cytokinesis”
- Thomas D. Pollard · Salk Institute For Biological Studies$12,844,618
- Erfei Bi · University Of Pennsylvania$12,673,251
- Bruce W Stillman · Cold Spring Harbor Laboratory$12,122,230
- Kathleen L Gould · Vanderbilt University$9,942,076
- Dannel McCollum · Univ Of Massachusetts Med Sch Worcester$9,110,453
- Ziyin Li · University Of Texas Hlth Sci Ctr Houston$9,071,689
Research focus
CytokinesisDrug DiscoveryAnticancer ActivityAnticancer ResearchDrug DevelopmentBaseBiochemicalBiologicalBreast Cancer PatientBreast Cancer TreatmentAngiogenesisAurora B KinaseCancer EtiologyCancer ImmunotherapyCancer PatientCancer TherapyCancer TypeCareerCell DeathCell DivisionCellsCessation Of LifeCancer BiologyDrug Interactions
Grant awards (5)
Identification of Dual CSF-1R/Aurora B Kinase Inhibitors as a Novel Breast Cancer Treatment Paradigm$78,427
K00 · FY2020 · CA · contact PI
Identification of Dual CSF-1R/Aurora B Kinase Inhibitors as a Novel Breast Cancer Treatment Paradigm$74,044
K00 · FY2019 · CA · contact PI
Identification of Dual CSF-1R/Aurora B Kinase Inhibitors as a Novel Breast Cancer Treatment Paradigm$73,903
K00 · FY2018 · CA · contact PI
Identification of Dual CSF-1R/Aurora B Kinase Inhibitors as a Novel Breast Cancer Treatment Paradigm$44,044
F99 · FY2017 · CA · contact PI
Identification of Dual CSF-1R/Aurora B Kinase Inhibitors as a Novel Breast Cancer Treatment Paradigm$45,076
F99 · FY2016 · CA · contact PI